Cardiothoracic & vascular anesthesia

Application of Alfentanil Combined With Dexmedetomidine for Conscious Sedation of Patients During Transesophageal Echocardiography Examination

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

Intravenous alfentanil combined with dexmedetomidine effectively inhibits pharyngeal reflexes and demonstrates a favorable safety profile, with fewer incidents of hypotension but a higher incidence of manageable respiratory depression compared with the MD protocol.

Study context

Population
Outpatients undergoing transesophageal echocardiography (TEE) under conscious sedation, university-affiliated teaching hospital
Participants
80 outpatients
Comparison
Alfentanil + dexmedetomidine (AD) vs MD
  • ADn = 40
  • MDn = 40reference
Primary endpoint
Initial sedation success rate (pharyngeal reflex grade <3, no excessive sedation [Ramsay sedation score >4], no serious adverse effects)
Methodological detailsprospective, double-blind
  • Prospective
  • Double-blind

Primary result

As reported in the abstract

P < 0.001

Further findings

OutcomeADMDP value
Recovery timeSignificantly shorter in AD626.25 ± 295.80768.33 ± 310.43P < 0.05

Safety

Hypotension

P < 0.05

Respiratory depression

P < 0.01

Respiratory depression

No hypoxia and asphyxia in either group

Serious complications

No serious complications in either group

Original publication

Application of Alfentanil Combined With Dexmedetomidine for Conscious Sedation of Patients During Transesophageal Echocardiography Examination. J Cardiothorac Vasc Anesth. Published 30 January 2025. doi:10.1053/j.jvca.2025.01.032

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.